Callitas Health (MPHMF) Stock Price, News & Analysis

Company Overview

Callitas Health Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for women’s health. The company’s research has centered on treatments for female sexual dysfunction and other conditions where alternative drug-delivery methods may improve convenience and patient acceptance.

Callitas has primarily advanced intranasal pharmaceutical products, including an investigational intranasal formulation of bremelanotide for female sexual dysfunction. The nasal-delivery approach is intended to provide a non-injectable alternative to existing treatment options, although the company’s products remain subject to clinical development and regulatory approval.

The company was formerly known as M Pharmaceutical Inc. Publicly available information about Callitas Health’s current operations, geographic reach and leadership is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 18,885 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Measuring & controlling devices, not elsewhere classified
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MPHMF
• CIK: N/A
• Web: www.callitas.com
• Phone: (859) 868-3131
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $530 thousand
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -3.50